Asia's No. 1 company manufacturing and selling culture media
First written in FY2024. 2 of 3 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026RestatedAnnual report
「Priority strategy 1: Tissue culture business / By leveraging its strength in providing end-to-end services from development through manufacturing and sales, the company aims to become Asia's No. 1 media manufacturer and supplier by supplying products suited to various cell types and developing products that meet new needs.」
The company continues to pursue the goal of becoming No. 1 in Asia through end-to-end services, product supply and product development. - FY2025RestatedAnnual report
「The company conducts active joint research with universities and businesses. By expanding its portfolio of products developed through this research and strengthening its sales organisation, it aims to develop new customers and projects and expand its network of distributors across Asia, thereby achieving the No. 1 sales volume in Asia for cell culture media.」
The company continues to target No. 1 in Asia and explicitly identifies joint research, portfolio expansion, sales-force strengthening and distributor-network expansion as the means to achieve it. - FY2024First statedAnnual report
「By leveraging its strength in providing end-to-end services from development through manufacturing and sales, the company aims to become Asia's No. 1 media manufacturer and supplier by supplying products suited to various cell types and developing products that meet new needs.」
The company aims to become No. 1 in Asia through end-to-end services, product supply and product development.